Citi Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $92
Barclays Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $86
Bullish Outlook: Boston Scientific Earns 'Buy' Rating With Upward Financial Revisions and Increased Price Target
Piper Sandler Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $90
Piper Sandler Keeps Their Buy Rating on Boston Scientific (BSX)
Boston Scientific's Market Position: Hold Rating Despite Favorable CMS Ruling on Farapulse
Argus Adjusts Price Target on Boston Scientific to $90 From $95
Daiwa Securities Adjusts Price Target on Boston Scientific to $83 From $81, Maintains Buy Rating
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Boston Scientific (BSX)
UBS Adjusts Boston Scientific Price Target to $94 From $90, Maintains Buy Rating
Raymond James Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $91
Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $92
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $85 to $91
Boston Scientific Price Target Raised to $91.00/Share From $90.00 by Baird
Buy Rating Reiterated for Boston Scientific on Strong Quarterly Performance and Uplifted Outlook
Citi Sticks to Its Buy Rating for Boston Scientific (BSX)
Boston Scientific Analyst Ratings
Redburn Atlantic Adjusts Price Target on Boston Scientific to $85 From $79, Maintains Buy Rating
Buy Rating Affirmed: Boston Scientific's Strong Performance and Upward Financial Projections
Evercore ISI Adjusts Price Target on Boston Scientific to $82 From $81